Anika Therapeutics (ANIK) PT Lifted to $35 at Summer Street Post Q3

November 1, 2013 8:50 AM

Summer Street analyst Mark Landy boosted his price target on Buy-rated Anika Therapeutics (NASDAQ: ANIK) from $28 to $35 following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found